Strs Ohio Madrigal Pharmaceuticals, Inc. Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 2,600 shares of MDGL stock, worth $566,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,600

Previous 800 225.0%

Holding current value

$566,254

Previous $213,000 241.78%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$193.33 - $291.99 $347,994 - $525,582	1,800 Added 225.0%	2,600 $728,000
Q4 2023 Jan 30, 2024	SELL	$120.4 - $237.13 $108,360 - $213,417	-900 Reduced 52.94%	800 $185,000
Q3 2023 Oct 26, 2023	SELL	$146.04 - $225.78 $452,724 - $699,918	-3,100 Reduced 64.58%	1,700 $248,000
Q2 2023 Jul 31, 2023	BUY	$203.88 - $312.0 $61,164 - $93,600	300 Added 6.67%	4,800 $1.11 Million
Q1 2023 Aug 02, 2023	SELL	$231.06 - $307.08 $69,318 - $92,124	-300 Reduced 6.25%	4,500 $1.09 Million
Q1 2023 Apr 27, 2023	BUY	$231.06 - $307.08 $854,922 - $1.14 Million	3,700 Added 462.5%	4,500 $1.09 Million
Q4 2022 Jan 26, 2023	SELL	$58.39 - $296.54 $29,195 - $148,270	-500 Reduced 38.46%	800 $232,000
Q3 2021 Oct 22, 2021	SELL	$78.35 - $105.02 $297,730 - $399,076	-3,800 Reduced 74.51%	1,300 $103,000
Q2 2021 Jul 26, 2021	BUY	$97.2 - $137.59 $38,880 - $55,036	400 Added 8.51%	5,100 $496,000
Q1 2021 Apr 23, 2021	SELL	$108.54 - $125.2 $43,416 - $50,080	-400 Reduced 7.84%	4,700 $549,000
Q4 2020 Jan 25, 2021	BUY	$110.06 - $133.7 $550,300 - $668,500	5,000 Added 5000.0%	5,100 $566,000
Q2 2020 Jul 23, 2020	BUY	$60.13 - $125.71 $6,013 - $12,571	100 New	100 $11,000
Q1 2019 Apr 19, 2019	SELL	$103.48 - $143.84 $310,440 - $431,520	-3,000 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$94.77 - $215.54 $75,816 - $172,432	-800 Reduced 21.05%	3,000 $338,000
Q2 2018 Aug 06, 2018	SELL	$101.55 - $313.9 $243,720 - $753,360	-2,400 Reduced 38.71%	3,800 $1.06 Million
Q1 2018 Apr 20, 2018	BUY	$93.35 - $149.04 $196,035 - $312,984	2,100 Added 51.22%	6,200 $724,000
Q4 2017 Jan 23, 2018	BUY	$39.35 - $97.37 $114,115 - $282,373	2,900 Added 241.67%	4,100 $376,000
Q3 2017 Oct 23, 2017	BUY	$15.48 - $46.19 $18,576 - $55,428	1,200	1,200 $53,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

21.9M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.72B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account